Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

Nord France InvestContact 

New biopharma start-up at Lille's Institut Pasteur

10 Aug 2016 | Health Nutrition, A region on the move

A revolutionary start-up has just seen the light of day at the Institut Pasteur campus in Lille. Immune InsighT is a biotech business specialized in analyses to confirm new drug candidates are safe. The company harnesses rare expertise to offer a unique services to clients around the world.

Lille's Institut Pasteur is an international pace-setter and a key player in medical research. Over the past fifteen years, a dozen start-ups have been set up on its campus or through its research teams—including Immune InsighT in 2016.

Immune InsighT offers an all-new, high-end method for confirming the safety of new drug candidates designed to treat cancer, transplants, auto-immune system and inflammatory illnesses, and applications in agrifood and the cosmetic industry prior to the launch of clinical tests. This fast-moving young company offers unique services worldwide.

Completing the full range of tests offered by Immune InsighT early on enables client companies to identify the undesirable effects of drug candidates or other molecules on the immune system both reliably and quickly—and to anticipate the potential failure of a long and costly clinical trial well in advance. 

 

Source: Lille's Institut Pasteur

Back to news

News

Hauts-de-France ranked France’s 2nd-most attractive region in 2018

Once again, Hauts-de-France took high honors for foreign direct investment, ranking No. 2 in France for jobs and No. 1 for industrial projects. Learn more about our region’s attractiveness for business from...

Procter & Gamble’s latest investment in Amiens

After a global investment of €300M in five years, P&G is reinjecting €50M into its Amiens site. Read about the regional assets that convinced the leading multinational consumer goods company to invest...

All news